Thilo Schroeder
InvestorPartner at Nextech Invest
Zurich, Switzerland
Writes $100K – $5M checks · typically $1.5M
About
Oncology-focused investor who has been with Nextech since 2012, specializing in precision medicines and targeted therapies. Holds multiple current and past board seats at publicly traded and private biotech companies.
Experience
- Nextech Invest Ltd.Managing Partnercurrent2012 — presentZürich und Umgebung, Schweiz
- Synnovation TherapeuticsMember Board of Directorscurrent2023 — present
- Exo TherapeuticsBoard Membercurrent2021 — presentBoston, Massachusetts, United States
- Atavistik BioMember Board Of Directorscurrent2021 — present
- MOMA TherapeuticsBoard Membercurrent2020 — present
- Circle Pharma, Inc.Board Membercurrent2020 — present
- REVOLUTION MedicinesMember Board Of Directorscurrent2018 — presentRedwood City, CA, USA
- IDRxBoard Observer2022 — 2025
- Alterome Therapeutics, IncMember Board Of Directors2022 — 2024
- Mariana OncologyBoard Observer2023 — 2024
- CARGO TherapeuticsBoard Observer2023
- PMV Pharmaceuticals, Inc.Member Board Of Directors2019 — 2023
- Silverback TherapeuticsBoard Member2020 — 2022
- IDEAYA BiosciencesMember Board Of Directors2018 — 2020
- Black Diamond TherapeuticsBoard Observer2018 — 2020
- ImaginAbMember of the Board of Directors2016 — 2020Großraum Los Angeles und Umgebung
- Peloton TherapeuticsMember of the Board of Directors2014 — 2019Dallas/Fort Worth und Umgebung
- Blueprint MedicinesMember of the Board of Directors2014 — 2015Großraum Boston und Umgebung
- SiROP AssociationPresident2007 — 2013Zürich und Umgebung, Schweiz
- University of ZurichPHD Student2007 — 2012
Education
- University of ZurichPhD, Biochemistry; Structural biology and protein engineering
- ESBS2006, Biotechnology; Protein biochemistry2003 — 2006
- Klostergymnasium GroßkrotzenburgHigh school diploma
- Life Science Zurich Graduate School, ETH |Universityof the PhD Program, Molecular Life Science
- Technische Universität DarmstadtVordiplom, Biology; Molecular biology
Same school
Also attended University of Zurich66
Christoph FreiPartner, Head of Energy at Emerald Technology Ventures AgAndy WeymannVenture Partner, Frontiers in Health & Bio Investments at Verve VenturesDavid FischerInvestor at FELIX CAPITALJohannes ClaussSerial Entrepreneur, Investor and Mentor at tokentus investment AGMartin ScherrerPartner & Head of Managed Funds at RedstonePatrik BrudererCFO at CV Labs
+ 60 more
Also attended Technische Universität Darmstadt19
Christina TakkeManaging Partner at V-Bio VenturesMathias FalcenbergVenture Partner at V-Bio VenturesAlexander HuberCFO at UVC PartnersTheo WoikManaging Partner at C3 Venture CapitalHubertus MeineckeManaging Director & Senior Partner; Global Leader, Climate & Sustainability Practice at The Boston Consulting GroupTom KönigCTO at w3 fund
+ 13 more
Shared employers
Also worked at Nextech Invest Ltd.6
Also worked at PMV Pharmaceuticals, Inc.1
Also worked at IDEAYA Biosciences1
Also worked at Blueprint Medicines6
Deals · 1
Revolution MedicinesBoard seat
via Nextech Invest · filed Jul 2018 · $56.4M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Nextech Invest
Alessia Jaeggli
Executive Assistant at Nextech Invest
Alexis Borisy
Chairman at Nextech Invest
Alfred Scheidegger
Managing Partner at Nextech Invest
Alice T. Shaw
Science Partner at Nextech Invest
Alina Levchuk
Head of Investor Relations at Nextech Invest
Amy Nelson
Executive Assistant at Nextech Invest
Antoni Ribas
Science Partner at Nextech Invest
Benjamin Cravatt
Science Partner at Nextech Invest
Network5
Alfred Scheidegger
Managing Partner at Nextech Invest
Gabor Gyulveszi
Senior Associate at Nextech Invest
Gretchen van Steenwyk
Analyst at Nextech Invest
Jakob Loven
Partner at Nextech Invest
Melissa McCracken
Partner at Nextech Invest
Investors connected to Thilo in public investor directories — a warm-intro map.





%20(4).avif)



























